HSINCHU, Aug. 1, 2024 /PRNewswire/ — M31 Technology Corporation (M31), a leading global provider of silicon intellectual property (IP), announced a collaboration with Tower Semiconductor yielding the successful development of static random access memory (SRAM) and read-only memory (ROM)…
Month: August 2024
SHANGHAI, Aug. 1, 2024 /PRNewswire/ — Marriott International, Inc. recently announced that it has signed an agreement with Zhong An Commercial Group, part of China New City Group, to bring the W Hotels brand to Hangzhou. Anticipated to open in 2031, W Hangzhou will be located at the…
BOSTON, Aug. 1, 2024 /PRNewswire/ — July 29-31 – The 4th mRNA Therapeutics Summit, one of the most important conferences in the global mRNA industry, took place in Boston, USA. Over 400 industry experts and 65 leading researchers in mRNA development gathered to discuss the latest…
AUSTIN, Texas, Aug. 1, 2024 /PRNewswire/ — The Selection Committee for the Violet Sky Mural Project is thrilled to announce the six talented artists who have been selected as finalists for the highly anticipated Violet Sky Mural Project. This project aims to transform Violet Sky into a…
Week-long Conference Also Recognizes “Best of” Industry With Premier Awards DENVER, Aug. 1, 2024 /PRNewswire/ — SIGGRAPH 2024 was a milestone conference for many reasons. It was the first time the world’s premier conference on computer graphics and interactive techniques has returned to…
PARAMUS, N.J, Aug. 1, 2024 /PRNewswire/ — Octapharma USA, Inc. has announced the expanded approval of fibryga®, Fibrinogen (Human) Lyophilized Powder for Reconstitution, for fibrinogen replacement in bleeding patients with acquired fibrinogen deficiency (AFD) by the U.S. Food and Drug…
PARAMUS, N.J, Aug. 1, 2024 /PRNewswire/ — Octapharma USA, Inc. has announced the expanded approval of fibryga®, Fibrinogen (Human) Lyophilized Powder for Reconstitution, for fibrinogen replacement in bleeding patients with acquired fibrinogen deficiency (AFD) by the U.S. Food and Drug…
SAN FRANSCISO and SUZHOU, China, Aug. 1, 2024 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, cardiovascular and…
SAN FRANSCISO and SUZHOU, China, Aug. 1, 2024 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, cardiovascular and…
LOS ANGELES, Aug. 1, 2024 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Paragon 28, Inc. (“Paragon 28” or “the Company”) (NYSE: FNA) for violations of the securities laws. The…